NPI: 1588088694 · BALTIMORE, MD 21215 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/10/2014
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/10/2014 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,861 | $20K |
| 2019 | 4,301 | $31K |
| 2020 | 4,274 | $35K |
| 2021 | 5,297 | $50K |
| 2022 | 3,644 | $65K |
| 2023 | 5,127 | $137K |
| 2024 | 3,140 | $125K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 5,674 | 727 | $321K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,331 | 867 | $79K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 231 | 132 | $31K |
| 83970 | 619 | 559 | $16K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,729 | 576 | $15K |
| J1756 | Injection, iron sucrose, 1 mg | 301 | 100 | $1K |
| A4657 | Syringe, with or without needle, each | 1,954 | 1,122 | $1K |
| 82728 | 715 | 644 | $0.00 | |
| 83550 | 577 | 509 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 112 | 43 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 44 | 44 | $0.00 |
| 83540 | 707 | 635 | $0.00 | |
| 85041 | 826 | 751 | $0.00 | |
| 85048 | 824 | 750 | $0.00 |